|
Israel's Week in Business & Technology
The week's top stories | | Contents |
| |
|
|
Wound cure co MacroCure raises $13m Viola Equity Partners invested $10 million, and current investors Pontifax and Docor invested $3 million.
|
Alcatel Lucent opens global cloud unit in Israel Alcatel Lucent appointed Dor Skuler, 34, as VP cloud enablement to manage the center.
|
EU regulator probes Teva sleep drug deal There are suspicions that Teva and Cephalon worked together to keep Provigil out of the European market.
|
Defense co Arotech files $35m Nasdaq shelf prospectus The company will use proceeds from the offerings for general business purposes, R&D, production, and acquisitions.
|
Industrial Buildings to sell Toronto property at a loss The company sold the Kipling residential complex for C$44.5 million.
|
Better Place to begin electric car sales in August The company has reportedly closed its visitors center at the Glilot Junction to convert it into a sales center.
|
Egyptian pipeline attack again stops gas flow An unidentified armed gang attacked the pipeline near El Arish, which carries natural gas to Israel and Jordan.
|
Negev to get new water recycling plant The project is being developed jointly by the Defense Ministry and Ramat Negev Regional Council.
|
Ramat Gan mayor to be indicted for bribery Zvi Bar's indictment will be subject to a hearing before State Prosecutor Moshe Lador for Bar in a few months.
|
Playtech reports revenue growth amid gambling uncertainties Playtech's gross revenue rose 7% to €46.6 million for the first quarter.
|
Harel Insurance affiliates with Germany's HDI Gerling Harel's business clients who operate abroad can receive services from HDI Gerling.
|
Arkia to halt Saturday leasing for El Al Israir is considering a similar move, which would mean El Al could no longer operate Saturday flights.
|
Amdocs reports stronger than expected results The business support systems company predicts even higher revenue and earnings per share for the third fiscal quarter.
|
Deutsche Bank: Markets overreacted on Teva Merrill Lynch slashed its target price for Teva to $58, still well above its Nasdaq close on Monday of $45.71.
|
Bank of Israel limits variable rate mortgages From May 5, only one third of the total mortgage taken can be at a variable interest rate, making the loan 1% more expensive.
|
Teva's credibility gap Positive statements from Teva, and analysts, are not convincing investors.
|
Unchanged interest rate could prove expensive There is no solution other than higher interest rates to the problems that the Israeli economy now faces.
|
Egyptian gas sabotage hands victory to Tshuva In
December, Yosef Maiman and EMG had $15 billion in contracts for
Egyptian gas, while Tamar only had three letters of intent for $10
billion.
|
Fischer scores a mortgage bulls-eye The banks have a variable rate mortgage portfolio of NIS 127.5 billion.
|
The season for Netanyahu The prime minister's penchant for doing nothing is just what we need at the moment. |
|
|